Medtronic plc ( MDT)

Company > Health Care > Biotechnology: Electromedical & Electrotherapeutic Apparatus

     LAST CLOSE
            

      $ 115.27 ( -2.68)

     TRADING VOLUME
           

       5,049,300

     MARKET CAP
            

      $ 154.8B

     52-WEEK HIGH/LOW
           

      $ 72.92 - $119.74









     PREVIOUS    ESTIMATE

                2020           2021

          $ 0 | -

     P/E RATIO    P/E RATIO

             Trailing           Forward

           0 | -

     P/E RATIO    P/E RATIO

             Trailing           Forward

           - | -

     P/E RATIO    P/E RATIO

             Trailing           Forward

           - | -











MDT
S&P 500
     30-DAY CHANGE

          -1.52%
           -0.41%

     90-DAY CHANGE

          1.25%
           3.86%

180-DAY CHANGE

          9.01%
           12.11%

52-WEEK CHANGE

          16.36%
           29.26%









     DIVIDEND

      0.54

   DIVIDEND YIELD

0.47%

OUTSTANDING

1,343,045,417

50-DAY AVG VOLUME

3335605.98









     FISCAL YEAR END

     
      Apr 27

     Last Earning Date

     
      Nov 24, 2020

     EX-DIVIDEND DATE

     
      Dec 26, 2019

     EX-DIVIDEND DATE

     
      Dec 26, 2019

Ratios

      BOOK VALUE
            

      $37.15

      DEBT TO EQUITY
            

      0.47

      RETURN ON EQUITY
            

      6.11%

Stock Price Chart +

Quarterly Returns +

Year 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 - -19.8 0.1 -0.1 13.7 -2 8.4 7.2 14.5 3.1 -
Q2 - 1.7 7.1 10.5 10.2 15.7 -4.5 4.1 10.6 -1.5 -
Q3 - 14 10.8 15 -11.4 0.6 -9.2 -2.4 2.9 10.8 -
Q4 - 10.6 3.7 -8.1 4.1 -17.1 15.5 17.6 8.9 -4.1 -

Monthly Returns +

Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 - - - - - - - - - - - -
2020 3.06 -13.81 -9.74 8.26 0.97 -6.98 5.21 11.39 -2.72 -4.89 14.34 1.69

Annual Returns +

Year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Returns66%-15%-10%7%3%17%-6%-5%-36%43%
Year 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Returns-14%6%11%43%28%9%-5%16%15%24%3%-0%

Financial Statements

View More


Income Statement


Millions of US $ except per share data 2020-04-302019-04-302018-04-30
Revenue 289133055729953
Cost Of Goods Sold 942491559055
Gross Profit 194892140220898

Balance Sheet


Millions of US $ except per share data 2020-04-302019-04-302018-04-30
Cash On Hand 10948984811227
Notes And Loans Receivable ---
Inventory 422937533579

Cash Flow Statement


Millions of US $ except per share data 2020-04-302019-04-302018-04-30
Net Income/Loss 480646503095
Total Depreciation And Amortization - Cash Flow 266326592631
Other Non-Cash Items -513521-986


Income Statement


Millions of US $ except per share data 2020-10-312020-07-312020-04-30
Revenue 764765075997
Cost Of Goods Sold 270525052264
Gross Profit 494240023733
Research And Development Expenses 639621568
SG&A Expenses 260024172359
Other Operating Income Or Expenses -14911417
Operating Expenses 671758345681
Operating Income 930673316
Total Non-Operating Income/Expense -405-89-111
Pre-Tax Income 525584205
Income Taxes 3193-434
Income After Taxes 494491639
Other Income ---
Income From Continuous Operations 494491639
Income From Discontinued Operations ---
Net Income 489487646
EBITDA 16011342988
EBIT 930673316
Basic Shares Outstanding 1344.41341.91340.7
Shares Outstanding 1352.113501351.1
Basic EPS 0.360.360.48
EPS - Earnings Per Share 0.360.360.47

Balance Sheet


Millions of US $ except per share data 2020-10-312020-07-312020-04-30
Cash On Hand 142771301210948
Notes And Loans Receivable ---
Inventory 448445514229
Other Current Assets 192720702209
Total Current Assets 260362450922031
Property, Plant, And Equipment 493848824828
Long-Term Investments ---
Goodwill And Intangible Assets 596245938458904
Other Long-Term Assets 211221432094
Total Long-Term Assets 698506939768658
Total Assets 958869390690689
Total Current Liabilities 120711308610366
Long Term Debt 259672286722021
Other Non-Current Liabilities 628162796256
Total Long Term Liabilities 334993037729451
Total Liabilities 455704346339817
Common Stock Net ---
Retained Earnings (Accumulated Deficit) 275262781728132
Comprehensive Income -3843-3782-3560
Other Share Holders Equity ---
Share Holder Equity 503165044350872
Total Liabilities And Share Holders Equity 958869390690689
Receivables 534848764645
Pre-Paid Expenses ---

52-Week High/Low

Annual Earnings







Year Apr Jan Jul Oct Annual
2005 0.26 0.67 0.45 0.16 1.48
2006 0.51 0.59 0.55 0.61 2.09
2007 0.59 0.58 0.61 0.70 2.41
2008 0.64 0.48 0.07 0.63 1.87
2009 0.40 0.78 0.62 0.10 1.84
2010 0.76 0.52 0.75 0.86 2.79
2011 0.77 0.82 0.86 0.72 2.86
2012 0.83 0.63 0.88 0.94 3.41
2013 0.93 0.89 0.97 0.94 3.37
2014 0.87 0.83 0.75 0.45 3.02
2015 1.01 1.16 1.02 1.03 4.22
2016 1.06 1.27 1.03 1.12 4.48
2017 1.12 1.33 1.12 1.07 4.64
2018 1.17 1.42 1.17 1.22 4.98
2019 1.29 1.54 1.26 1.31 5.4
2020 0.58 - - - -

Earnings Calendar


Quarter | Rep. Date
2020
| May 21
| Aug 25
Quarter | Rep. Date
2019
Jan | Feb 19
Apr | May 23
Jul | Aug 20
Oct | Nov 19
Quarter | Rep. Date
2018
Jan | Feb 20
Apr | May 24
Jul | Aug 21
Oct | Nov 20
Quarter | Rep. Date
2017
Jan | Feb 21
Apr | May 25
Jul | Aug 22
Oct | Nov 21
Quarter | Rep. Date
2016
Jan | Mar 01
Apr | May 31
Jul | Aug 25
Oct | Nov 22

Dividend History


Year Mar Jun Sep Dec Annual
2019 0.5 0.54 0.54 0.54 2.12
2018 0.46 0.5 0.5 0.5 1.96
2017 0.43 0.46 0.46 0.46 1.81
2016 0.38 0.43 0.43 0.43 1.67

Ex - Dividend Data & Date


Year Mar Jun Sep Dec Annual
2019 Mar 21 | 0.5 Jul 05 | 0.54 Sep 26 | 0.54 Dec 26 | 0.54 2.12
2018 Mar 22 | 0.46 Jul 05 | 0.5 Sep 27 | 0.5 Dec 27 | 0.5 1.96
2017 Mar 22 | 0.43 Jul 05 | 0.46 Sep 28 | 0.46 Dec 28 | 0.46 1.81
2016 Mar 22 | 0.38 Jul 06 | 0.43 Sep 27 | 0.43 Dec 21 | 0.43 1.67